ORIC Pharmaceuticals will advance its prostate cancer drug to Phase III trials after it showed survival benefit in a Phase Ib study. The Himalayas-1 trial will evaluate rinzimetos ...
AstraZeneca has reported positive results from the efzimfotase alfa Phase III clinical trial programme for HPP, a rare metabolic bone disorder.
The UK is currently facing a meningitis outbreak, especially in the younger population. As of 24 March, 20 laboratory cases were confirmed.
LabConnect has introduced the smartphone-based SampleGISTICS 2.0 application to digitise clinical trial sample capture.
MSD’s oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor has reduced low-density lipoprotein cholesterol (LDL-C) levels when combined with background therapies ...
Boston presented the pair of trial readouts at the 2026 American College of Cardiology (ACC) conference in New Orleans.
The analysis supports making dapagliflozin part of standard inpatient heart failure (HF) pathways rather than postponing it until discharge.
Analysts note that treatment durability is a key unmet need in HS, and will define a drug’s commercial success on the market.
Idorsia has reported positive top-line data from its Phase II dose-finding trial evaluating daridorexant for paediatric insomnia disorder.
ALS is a progressive neurodegenerative disease impacting the nervous system over time. Credit: ANDREI ASKIRKA / Shutterstock.com. Prilenia Therapeutics and Ferrer have enrolled the first participant ...
Increasing clinical trial activity worldwide reflects growing scientific confidence that new therapeutic strategies may begin to slow ALS progression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results